A - Z index - C

The section presents an alphabetical listing of all pages of the website. Choose a letter from the links below to view all pages with titles that start with that letter. Alternatively view the sitemap, which lists all pages by their topic and placement in the navigation.

• Cancellations and withdrawals

• Car boot sales: availability of medicines

• Cardiac pacemakers and defibrillators (implantable)

• Cardiology - a one-stop resource for cardiology practitioners

• Cardiovascular safety of Cox-2 inhibitors and non-selective NSAIDs

• Cardiovascular, Diabetes, Renal, Respiratory and Allergy Expert Advisory Group of the Commission on Human Medicines

• Care home staff - a one-stop resource for care home staff

• Case studies

• Case study 1

• Case study 2

• Cellphones (mobile phones)

• Change of ownership applications

• Changes to labelling and patient information leaflets for all medicines subject to self certification by the applicant and formal notification to the MHRA

• Changes to medicines names: BANs to rINNs

• Changes to medicines names: sulphate to sulfate

• Changes to the contact person or the contact details

• Changes to the submitted documentation during evaluation

• Changing the name of a company for authorisations held under Medicines Regulations

• Chemistry, Pharmacy and Standards Expert Advisory Group (CPSEAG) of the Commission on Human Medicines

• Chemistry, Pharmacy and Standards subcommittee of Committee on Safety of Medicines

• Child resistant packaging

• Children: Medicines for

• Chiropodists: exemptions from Medicines Act restrictions

• Citalopram overdose

• Clinical investigations for medical devices

• Clinical Laboratories: Good Clinical Practice (GCP)

• Clinical Trials Expert Advisory Group of the Commission on Human Medicines

• Clinical trials for medical devices

• Clinical trials for medicines

• Clinical trials for medicines: Academic trials

• Clinical trials for medicines: Applying to conduct a clinical trial

• Clinical trials for medicines: FAQs

• Clinical trials for medicines: Hot topics

• Clinical trials for medicines: Implementation of the Clinical Trials Directive in the UK

• Clinical trials for medicines: Is a clinical trial authorisation (CTA) required?

• Clinical trials for medicines: Legislation

• Clinical trials for medicines: Legislation

• Clinical trials for medicines: Managing your clinical trial authorisation

• Clinical trials for medicines: PET trials

• Clinical trials for medicines: Risk adapted approaches to management of clinical trials

• Clinical trials for medicines: Safety reporting - SUSARs and DSURs

• Clinical trials for medicines: Special Interest Groups

• Clinical trials for medicines: Submitting a notification for a trial

• Clinical trials for medicines: UK clinical trial authorisation assessment performance

• Clinical trials: Phase I Accreditation Scheme

• Co-proxamol overdose

• Cochlear implants

• Codeine overdose

• Commission on Human Medicines

• Commission on Human Medicines and the Industry Forum: Minutes of meetings

• Commission on Human Medicines: Expert Advisory Groups

• Commission on Human Medicines: Members

• Committee on Blood Pressure Monitoring in Clinical Practice

• Committee on Safety of Medicines

• Committee on Safety of Medicines: Minutes

• Committee on the Safety of Devices

• Committee on the Safety of Devices: Members

• Committee on the Safety of Devices: Members

• Committee on the Safety of Devices: Minutes

• Committee on the Safety of Devices: Minutes

• Committees

• Committees and referrals

• Common European Submissions Platform (CESP)

• Common technical specifications

• Communications and transparency, including web portals

• Communications enquiries

• Company names - changing the name of a company for authorisations held under Medicines Regulations

• Company-led recalls

• Company-led recalls

• Complaint form

• Complaints about advertising of medicines: Results of investigations

• Complaints about labelling and packaging of medicines

• Complaints about the MHRA

• Complaints procedure

• Complaints under the Freedom of Information Act (FOIA) 2000

• Compliance inspection and action: Your rights

• Conference documentation

• Conferences

• Conferences and education

• Conflicts of interest

• Conformity assessment for in vitro diagnostic medical devices

• Conformity assessment for medical devices

• Consultations

• Consultations: Devices

• Consultations: General

• Consultations: Medicines

• Consumer advice and information

• Consumer publications

• Contact list: Regulatory advice for devices

• Contact us

• Contrast media injectors: risk of air embolism

• Cookies

• Corporate Executive Team (CET)

• Corporate Executive Team (CET) members

• Corporate Executive Team (CET) minutes

• Corporate Plans

• Corporate Publications

• Cosmetic procedures: Supply and administration of injectable medicines

• Cosmetic surgery

• Counterfeit medical devices

• Counterfeit medicine recalls and previously seen counterfeits

• Counterfeit medicines

• Counterfeit medicines and devices

• Critical care - a one-stop resource for critical care practitioners

• Crown Copyright

• Current Problems in Pharmacovigilance

• Custom-made devices

• Customer Services